Hypertension Clinical Trial
Official title:
Harnessing Mobile Health Technology to Personalize the Care of Chronic Kidney Disease Patients: Medication Domain Randomized Controlled Trial
Patients with complex, long-lasting conditions such as chronic kidney disease (CKD) often take multiple medications and frequently have serious medication problems, arising from poor communication between doctors and patients. Prescription errors or misunderstandings can cause harm and lead to emergency room visits or even hospitalizations. To address these issues, medication reconciliation is now used by hospitals as a way to confirm the medication list of patients on admission to and discharge from hospital. However, a similar process does not exist outside the hospital setting. In recent years patients have become more proactive in undertaking activities with a direct bearing on their health. Such activities may include maintaining an accurate list of their medications. The rapid growth of the digital health arena has led to the development of a large number of commercially available mobile medication management apps for patients. These digital tools are 'stand-alone' products that are not integrated with the patients' pharmacy or health record system. They rely on patients to enter the list of their medications and update it as necessary. Moreover, few have a function to communicate medication changes or problems with their healthcare providers. Recently, an integrated smartphone, eKidneyCare, app system was developed with a medication management feature to help patients maintain an accurate mobile medication list. Patients' current medication information in the pharmacy database is uploaded onto their by a pharmacist and changes are tracked regularly through a bi-directional communication system. Updates to the medication list occur seamlessly by the pharmacist, and patients and their physicians are notified about any medication errors or serious adverse events. This study will determine whether our eKidneyCare app with its medication management feature will decrease medication errors and improve patient safety compared to the more traditional way of managing medications.
Background: Patients who have complicated conditions such as chronic kidney disease (CKD) are
at high risk for problems related to their medications. Often these problems occur because
doctors and patients do not communicate the right type of medication information to each
other. This causes many prescribing errors and can lead to patient harm, emergency visits, or
hospitalizations. To address this communication problem, hospitals now use a process called
"medication reconciliation" to confirm the medications patients are taking when they enter
and leave the hospital. However, the way that medication reconciliation is currently being
done, patients are not actively engaged or given tools to effectively communicate the
medications they are taking, changes that have been made, and what they are having trouble
with. Directly engaging patients in this process might help solve this problem, and mobile
technologies on smartphones may be a solution. Our study team has developed a mobile
application (app) called eKidneyCare, which has a specific medication component to help
patients communicate their medication information to all their doctors. This app can feed
medication information from the clinic's medical record to the patient's smartphone, and any
changes made to the medication list can be entered by the patient and sent back to the
central server to notify their doctors.
Study Design: We propose to conduct an open-label randomized controlled trial to assess the
medication related effectiveness and stakeholders' satisfaction of the eKidneyCare mobile app
compared to commercially available mobile apps like My MedRec for 12 months. This study will
be conducted in the renal clinics at University Health Network who oversee the clinical
management of advanced stage 4 to 5 CKD patients and end stage renal disease. On average,
patients of this clinic are aged 65 years or more and take 10-15 medications per day.
Objectives and Hypotheses Primary 1) To evaluate the effect of the eKidneyCare mobile app
compared to a commercially available stand alone mobile app (My MedRec) on unintentional
medication discrepancies in CKD patients. The use of the eKidneyCare app will have a greater
reduction medication discrepancy rates by enhancing patient self-care through bidirectional
communication of information.
Secondary
1. To determine the effect of the eKidneyCare mobile app compared to commercially available
stand along mobile app (My MedRec) on CKD-specific clinical outcomes. Patients actively
engaged in medication management will translate to improved clinical parameters such as
better blood pressure control.
2. To evaluate the direct costs and quality of life (QOL) associated with incorporating the
eKidneyCare mobile app compared to commercially available stand along mobile app (My
MedRec). Reduction in the unintentional medication discrepancy rate will offset the cost
of using the medication self-care app and will improve patients' quality of life.
3. To assess stakeholders' satisfaction in using the mobile app to manage CKD. Medication
self-care app will increase satisfaction among patients.
This study will evaluated if this app will decrease errors related to medications. It is
hypothesized that if patients use this app to report their medications to their doctors,
fewer errors will occur, which should eventually lead to reduced patient harm and healthcare
use.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |